General Pathology — MCQs

General Pathology Indian Medical PG Practice Questions and MCQs

Question 251: Protein content of <4mg/ml is seen in which of the following?

A. Dentigerous cyst
B. Periapical cyst
C. Keratocyst (Correct Answer)
D. Periodontal cyst

Explanation: **Explanation:** The protein content of cystic fluid is a significant diagnostic marker in differentiating odontogenic cysts. The correct answer is **Keratocyst** (specifically the Odontogenic Keratocyst or OKC). **Why Keratocyst is correct:** The Odontogenic Keratocyst (OKC) is characterized by a unique lining of parakeratinized stratified squamous epithelium [1]. This lining acts as an effective barrier, limiting the passage of serum proteins into the cystic lumen. Consequently, the soluble protein content in OKC fluid is characteristically low, typically **less than 4 g/dl (or 40 mg/ml)**. Furthermore, the presence of **keratin squames** and low levels of albumin and alkaline phosphatase are hallmark features of OKC fluid analysis. **Analysis of Incorrect Options:** * **Dentigerous, Periapical, and Periodontal Cysts:** These are non-keratinizing inflammatory or developmental cysts. Their epithelial linings are more permeable, allowing for the significant accumulation of serum proteins and inflammatory exudates [1]. The protein content in these cysts is generally much higher, typically exceeding **5–7 g/dl**, which is comparable to or higher than serum levels. **NEET-PG High-Yield Pearls:** * **OKC Protein Threshold:** Always remember the value **<4 g/dl** for OKC. If the protein level is >4 g/dl in a suspected OKC, it often indicates a secondary infection. * **Cholesterol Crystals:** While common in Periapical (Radicular) cysts (giving a "shimmering" appearance to the fluid), they are rarely seen in OKCs. * **Epithelium:** OKC has a characteristic **7-10 cell layer thick** epithelium with a **corrugated** parakeratin surface and a **palisaded basal layer** (often described as "tombstone" appearance). * **Clinical Behavior:** OKCs are known for high recurrence rates and an association with **Gorlin-Goltz Syndrome** (PTCH gene mutation) [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Head and Neck, p. 741. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Skin, pp. 1157-1158.

Question 252: Which of the following conditions is associated with a BRAF mutation?

A. Langerhans cell histiocytosis (LCH)
B. Colon carcinoma
C. Hairy cell leukemia (Correct Answer)
D. Acute myeloid leukemia (AML)

Explanation: **Explanation:** The **BRAF V600E mutation** is a high-yield genetic marker in pathology, representing a constitutive activation of the MAP kinase (RAS-RAF-MEK-ERK) signaling pathway, which promotes uncontrolled cellular proliferation. **Why Hairy Cell Leukemia (HCL) is the correct answer:** The BRAF V600E mutation is considered the **molecular hallmark** of Hairy Cell Leukemia [2]. It is present in nearly **100% of classic HCL cases**, making it a definitive diagnostic marker that distinguishes it from other B-cell lymphoproliferative disorders (like HCL-variant or Splenic Marginal Zone Lymphoma). This discovery has revolutionized treatment, as BRAF inhibitors (e.g., Vemurafenib) can be used in refractory cases. **Analysis of Incorrect Options:** * **Langerhans Cell Histiocytosis (LCH):** While BRAF V600E mutations are found in approximately 50-60% of LCH cases [2], it is not as pathognomonic or "classically" associated in the context of this specific question compared to the near-universal presence in HCL. * **Colon Carcinoma:** BRAF mutations occur in about 10% of colorectal cancers (often associated with microsatellite instability and the serrated pathway), but it is not the primary driver in the majority of cases. * **Acute Myeloid Leukemia (AML):** AML is more commonly associated with mutations in **FLT3, NPM1, or DNMT3A**. BRAF mutations are extremely rare in AML. **NEET-PG High-Yield Pearls:** * **BRAF V600E "Club":** Remember the mnemonic **"Melons Had Great Big Seeds"** — **Mel**anoma, **Ha**iry cell leukemia, **G**lioma (Pilocytic), **B**-type (Papillary) Thyroid Cancer, and **S**errated Colorectal polyps/cancer. * **HCL Diagnosis:** Look for "fried egg" appearance on bone marrow biopsy, "hairy" cytoplasmic projections [1], and **TRAP positivity** (Tartrate-Resistant Acid Phosphatase). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, p. 612. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 629-630.

Question 253: Which of the following is not associated with Down syndrome?

A. Trisomy 21
B. Mosaicism for chromosome 21
C. Robertsonian translocation involving chromosome 21
D. Deletion of chromosome 21 (Correct Answer)

Explanation: **Explanation:** Down syndrome (Trisomy 21) is caused by an **excess of genetic material** from chromosome 21. Therefore, a **deletion** (loss of genetic material) of chromosome 21 would not result in Down syndrome; rather, it would lead to distinct clinical features or, more commonly, be incompatible with life if it involves a large portion of the chromosome [1]. **Analysis of Options:** * **Trisomy 21 (Option A):** This is the most common cause (95% of cases), usually due to **meiotic non-disjunction**, most frequently occurring during maternal meiosis I [3]. * **Mosaicism (Option B):** Occurs in 1–2% of cases due to **mitotic non-disjunction** during early embryonic development [2,3]. These individuals have two cell lines (one normal, one trisomic) and often present with a milder phenotype [2]. * **Robertsonian Translocation (Option C):** Occurs in 3–4% of cases, typically involving the long arm of chromosome 21 attaching to another acrocentric chromosome (usually **14 or 22**) [2,3]. This is the only form that can be inherited from a carrier parent. **High-Yield Clinical Pearls for NEET-PG:** * **Most common cause:** Meiotic non-disjunction (correlated with advanced maternal age) [4]. * **Cardiac defect:** Endocardial cushion defects (Atrioventricular Septal Defect) are most common. * **GI associations:** Duodenal atresia ("Double bubble" sign) and Hirschsprung disease. * **Hematology:** Increased risk of **AMKL** (Acute Megakaryoblastic Leukemia) before age 5 and **ALL** (Acute Lymphoblastic Leukemia) after age 5. * **Neurology:** Early-onset Alzheimer’s disease due to the amyloid precursor protein (APP) gene being located on chromosome 21. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 168-169. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 170-171. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 171-172. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 92-93.

Question 254: What is the pathogenetic mechanism of HPV in causing cervical carcinoma?

A. Downregulation of p16INK4 protein
B. Degradation of cyclin D1
C. Genomic instability mediated by E6 and E7 proteins (Correct Answer)
D. Upregulation of BCL2

Explanation: **Explanation:** The oncogenic potential of High-Risk Human Papillomavirus (HR-HPV), particularly types 16 and 18, lies in the integration of the viral genome into the host DNA. This leads to the overexpression of two key oncoproteins: **E6 and E7** [2]. 1. **E6 Protein:** Binds to and facilitates the ubiquitin-mediated degradation of the **p53** tumor suppressor protein. Loss of p53 prevents apoptosis and impairs DNA repair [3]. 2. **E7 Protein:** Binds to the **Retinoblastoma (Rb)** protein, displacing the E2F transcription factor [2]. This promotes uncontrolled progression from the G1 to the S phase of the cell cycle. Together, the neutralization of these "gatekeepers" leads to profound **genomic instability**, the accumulation of mutations, and eventual malignant transformation [3]. **Analysis of Incorrect Options:** * **Option A:** HPV actually causes **upregulation of p16INK4a** [1]. Because E7 inhibits Rb, there is a negative feedback release that causes p16 to overexpress. In clinical practice, p16 immunohistochemistry is used as a surrogate marker for HR-HPV infection [1]. * **Option B:** HPV leads to an **increase** in cell cycle progression (via Cyclin E and A), not the degradation of Cyclin D1 [2]. * **Option D:** While BCL2 is an anti-apoptotic marker in many cancers (like Follicular Lymphoma), the primary driver in HPV-mediated cervical cancer is the E6-mediated inhibition of p53, not the direct upregulation of BCL2. **NEET-PG High-Yield Pearls:** * **HPV 16** is most commonly associated with Squamous Cell Carcinoma. * **HPV 18** is more frequently associated with Adenocarcinoma. * **E6** = **6** letters = **p53** (degradation). * **E7** = **7** letters = **Rb** (inhibition). * The viral protein **E2** normally inhibits E6/E7; its disruption during integration is the "trigger" for oncogenesis. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Female Genital Tract, pp. 1007-1008. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 334-335. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 226-227.

Question 255: The type of embolism typically seen following fractures of long bones is:

A. Thromboembolism
B. Air embolism
C. Fat embolism (Correct Answer)
D. Amniotic fluid embolism

Explanation: **Explanation:** **Fat Embolism** is the correct answer because long bones (like the femur and tibia) contain significant amounts of **yellow bone marrow**, which is rich in adipose tissue [1]. Following a fracture, the rupture of small marrow venules allows fat globules to enter the systemic circulation [1]. These globules can obstruct microvasculature and trigger a systemic inflammatory response. **Analysis of Options:** * **Thromboembolism (A):** This is the most common type of embolism overall, usually originating from Deep Vein Thrombosis (DVT) [3]. While trauma increases the risk of DVT due to stasis [2], it is not the *characteristic* embolism immediately associated with the mechanical release of marrow contents. * **Air Embolism (B):** This occurs when air is introduced into the circulation, typically via neck vein injuries, obstetric procedures, or improper IV catheter management [1]. * **Amniotic Fluid Embolism (D):** This is a catastrophic obstetric complication occurring during labor or postpartum when amniotic fluid enters maternal circulation [3]. **High-Yield Clinical Pearls for NEET-PG:** * **Fat Embolism Syndrome (FES):** Characterized by a "latent period" of 24–72 hours after injury. * **Classic Triad:** 1. Respiratory distress (dyspnea/hypoxemia), 2. Neurological symptoms (confusion/seizures), and 3. **Petechial rash** (typically over the chest, axilla, and conjunctiva). * **Diagnosis:** Primarily clinical (Gurd’s Criteria). Histologically, fat can be demonstrated in the lungs or brain using **Sudan Black** or **Oil Red O** stains on frozen sections. * **Treatment:** Primarily supportive (oxygenation); early fixation of fractures is the best preventive measure. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 146-147. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, p. 705. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Respiratory Tract Disease, pp. 323-324.

Question 256: A 65-year-old male diagnosed with lung carcinoma presents with a paraneoplastic syndrome and increased PTH. What is the probable cause of the increased PTH?

A. Parathyroid adenoma
B. Parathyroid hormone-related peptide (PTHrP) (Correct Answer)
C. Calcitonin
D. Calcitonin-related peptide

Explanation: ### Explanation **Correct Answer: B. Parathyroid hormone-related peptide (PTHrP)** **Underlying Concept:** This patient is presenting with **Humoral Hypercalcemia of Malignancy (HHM)**, a classic paraneoplastic syndrome [1]. In certain malignancies—most commonly **Squamous Cell Carcinoma of the Lung**—tumor cells secrete **Parathyroid Hormone-related Protein (PTHrP)** [1], [2]. PTHrP mimics the action of native PTH by binding to the same PTH-1 receptors in the bone and kidney [1]. This leads to increased osteoclastic bone resorption and renal calcium reabsorption, resulting in hypercalcemia [1], [3]. While the question mentions "increased PTH," in clinical practice, immunoassays often show elevated PTHrP while native PTH is actually suppressed due to negative feedback from high calcium levels [1]. **Analysis of Incorrect Options:** * **A. Parathyroid adenoma:** This is the most common cause of *Primary* Hyperparathyroidism [2], [3]. While it causes high PTH, it is a primary endocrine disorder, not a paraneoplastic syndrome associated with lung carcinoma [3]. * **C. Calcitonin:** Secreted by the parafollicular C-cells of the thyroid (and elevated in Medullary Thyroid Carcinoma), calcitonin functions to *lower* serum calcium, which contradicts the clinical presentation of hypercalcemia [3], [4]. * **D. Calcitonin-related peptide (CGRP):** This is a potent vasodilator and neurotransmitter; it does not play a primary role in calcium homeostasis or paraneoplastic hypercalcemia. **NEET-PG High-Yield Pearls:** * **Squamous Cell Carcinoma (Lung):** Most common lung cancer associated with **Hypercalcemia** (PTHrP) [1]. Remember: **S**quamous = **S**tony (Calcium). * **Small Cell Carcinoma (Lung):** Most common lung cancer associated with **ACTH** (Cushing syndrome) and **SIADH**. * **Diagnostic Tip:** In HHM, the biochemical profile typically shows **↑ Calcium, ↓ Phosphate, and ↓ native PTH** (but ↑ PTHrP). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 338-339. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Osteoarticular And Connective Tissue Disease, pp. 667-668. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 127-128. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 431-432.

Question 257: Which of the following is NOT a tumor marker?

A. None (Correct Answer)
B. HCG
C. Alpha-fetoprotein
D. CEA

Explanation: **Explanation:** The correct answer is **None** because all the other options listed (HCG, Alpha-fetoprotein, and CEA) are well-established biochemical tumor markers [4] used in clinical oncology for diagnosis, monitoring, and prognosis. **Analysis of Options:** * **HCG (Human Chorionic Gonadotropin):** This is a glycoprotein hormone normally produced by the placenta. As a tumor marker, it is highly sensitive for **Gestational Trophoblastic Disease** (Hydatidiform mole/Choriocarcinoma) [1] and certain **Germ Cell Tumors** [2] (specifically non-seminomatous germ cell tumors of the testis) [3]. * **Alpha-fetoprotein (AFP):** This is a plasma protein produced by the fetal yolk sac and liver. Pathologically, it is the hallmark marker for **Hepatocellular Carcinoma (HCC)** and **Yolk Sac Tumors** (Endodermal sinus tumors). * **CEA (Carcinoembryonic Antigen):** This is an oncofetal antigen. While not specific enough for primary screening, it is the primary marker used for monitoring recurrence and treatment response in **Colorectal Carcinoma**. It can also be elevated in pancreatic, gastric, and breast cancers. **Clinical Pearls for NEET-PG:** * **Most Specific Marker:** PSA (Prostate Specific Antigen) for Prostate Cancer (though it can rise in BPH). * **CA-125:** Standard marker for **Ovarian Cancer** (surface epithelial tumors). * **CA 19-9:** Associated with **Pancreatic Adenocarcinoma**. * **Calcitonin:** Specific marker for **Medullary Carcinoma of the Thyroid**. * **Rule of Thumb:** Most tumor markers are used for **monitoring response to therapy** and detecting recurrence rather than initial diagnosis (except for HCG and AFP in specific contexts). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Female Genital Tract, pp. 1044-1046. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Female Genital Tract, pp. 1035-1036. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 512-513. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 344-346.

Question 258: What is an example of Type IV Hypersensitivity?

A. Farmer's lung
B. Contact hypersensitivity (Correct Answer)
C. Immediate hypersensitivity
D. Myasthenia gravis

Explanation: **Explanation:** **Type IV Hypersensitivity**, also known as **Delayed-Type Hypersensitivity (DTH)**, is a cell-mediated immune response [1]. Unlike Types I, II, and III, it does not involve antibodies [4]. Instead, it is mediated by T-lymphocytes (CD4+ Th1 cells and CD8+ cytotoxic T cells). In **Contact Hypersensitivity** (e.g., reaction to poison ivy or nickel), small molecules called haptens bind to skin proteins [2], [3]. These are processed by Langerhans cells and presented to T cells, leading to a delayed inflammatory response (typically 48–72 hours later) [2]. **Analysis of Incorrect Options:** * **A. Farmer’s Lung:** This is an example of **Type III Hypersensitivity** (Immune complex-mediated). It involves the inhalation of actinomycetes, leading to the formation of antigen-antibody complexes in the alveoli. (Note: Chronic stages may involve Type IV, but it is classically categorized as Type III). * **C. Immediate Hypersensitivity:** This refers to **Type I Hypersensitivity**, which is IgE-mediated and involves mast cell degranulation (e.g., Anaphylaxis, Asthma) [4]. * **D. Myasthenia Gravis:** This is a **Type II Hypersensitivity** (Antibody-mediated). Antibodies are directed against the acetylcholine receptors at the neuromuscular junction, blocking neuromuscular transmission. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Hypersensitivity (ACID):** **A**naphylactic (I), **C**ytotoxic (II), **I**mmune-Complex (III), **D**elayed (IV). * **Classic Type IV Examples:** Mantoux Test (Tuberculin reaction), Granuloma formation (TB, Sarcoidosis), and Graft rejection (Cellular) [1], [2]. * **Key Cytokine:** **IFN-gamma** is the major cytokine secreted by Th1 cells in Type IV reactions to activate macrophages [1]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 173-174. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 174-175. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 218-219. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 216-218.

Question 259: In renal biopsy specimens, the Jones methenamine silver stain is used for which purpose?

A. To assess cellularity and architecture
B. To stain carbohydrate moieties in the membranes of the glomerular tuft
C. To enhance basement membrane structure visualization (Correct Answer)
D. To identify collagen deposition

Explanation: **Explanation:** **Jones Methenamine Silver (JMS)** stain is a specialized silver-based stain used extensively in renal pathology. The underlying principle involves the oxidation of carbohydrates (specifically glycoproteins) in the glomerular basement membrane (GBM) by periodic acid to form aldehydes. These aldehydes then reduce the silver cations in the methenamine silver solution to metallic silver, which appears black. 1. **Why Option C is correct:** The primary utility of JMS is to provide a sharp, high-contrast visualization of the **basement membrane**. It is the "gold standard" for detecting structural abnormalities such as **basement membrane thickening, "spikes"** (seen in Membranous Nephropathy) [1], and **"double contours" or "tram-tracking"** (seen in Membranoproliferative Glomerulonephritis) [2]. 2. **Why other options are incorrect:** * **Option A:** Cellularity and general architecture are best assessed using **Hematoxylin and Eosin (H&E)** or Periodic Acid-Schiff (PAS). * **Option B:** While JMS does react with carbohydrate moieties, the *purpose* of the stain in a renal biopsy context is specifically to delineate the basement membrane structure, not just to identify carbohydrates in general. * **Option C:** Collagen deposition (fibrosis) is best identified using **Masson’s Trichrome** stain, which stains collagen blue or green. **High-Yield Clinical Pearls for NEET-PG:** * **PAS vs. JMS:** Both stain the GBM, but JMS provides better resolution for detecting fine basement membrane defects like "spikes." * **Congo Red:** Used for identifying Amyloid deposits (Apple-green birefringence under polarized light). * **Prussian Blue:** Used to detect iron (hemosiderin) in cases of intravascular hemolysis. * **Oil Red O:** Used on frozen sections to identify lipid/fat. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Kidney, p. 921, 925-926. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 541-542.

Question 260: Which type of cells remain in the G0 phase?

A. Permanent cells
B. Labile cells
C. Intermitotic cells
D. Quiescent cells (Correct Answer)

Explanation: **Explanation:** The cell cycle is divided into phases (G1, S, G2, and M). Based on their proliferative capacity and relationship with the cell cycle, body cells are classified into three categories: **1. Why Quiescent Cells are Correct:** **Quiescent cells (Stable cells)** are typically in the **G0 phase** (resting phase) [2]. They have exited the cell cycle but retain the capacity to re-enter it in response to specific stimuli, such as growth factors or tissue injury [2]. Once stimulated, they move from G0 into the G1 phase to begin replication. * **Examples:** Parenchymal cells of the liver (hepatocytes), kidneys, and pancreas; mesenchymal cells like fibroblasts and smooth muscle cells [2]. **2. Analysis of Incorrect Options:** * **A. Permanent cells:** These cells are considered "terminally differentiated." They have permanently exited the cell cycle and cannot undergo division [1]. While they are technically in a non-replicative state, the term "G0" specifically refers to the reversible resting state of stable cells [2]. * *Examples:* Neurons, cardiac myocytes, and skeletal muscle cells [1], [2]. * **B. Labile cells:** These are continuously dividing cells [4]. They follow a rapid cell cycle, moving from one mitosis to the next without entering G0 [2]. * *Examples:* Hematopoietic cells in bone marrow, surface epithelia (skin, GI tract) [2], [4]. * **C. Intermitotic cells:** This is another term for labile cells that are constantly moving between mitotic divisions. **NEET-PG High-Yield Pearls:** * **Regeneration Power:** The liver is the classic example of quiescent cells; after a partial hepatectomy, hepatocytes exit G0 to regenerate the organ [4]. * **Chemotherapy:** Most chemotherapeutic agents target cells in the active cycle (S or M phase). Therefore, **permanent cells** and **quiescent cells** (while in G0) are generally resistant to these drugs. * **Stem Cells:** These are often quiescent but can be activated for tissue repair [3]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 78-79. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. With Illustrations By, pp. 37-38. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. With Illustrations By, pp. 38-39. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, pp. 112-113.

Practice by Chapter

Cell Injury and Cell Death

Practice Questions

Adaptations of Cellular Growth

Practice Questions

Accumulations and Deposits

Practice Questions

Acute and Chronic Inflammation

Practice Questions

Tissue Repair and Wound Healing

Practice Questions

Hemodynamic Disorders

Practice Questions

Genetic Disorders

Practice Questions

Environmental Pathology

Practice Questions

Nutritional Diseases

Practice Questions

Molecular Basis of Disease

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free